Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 18/20 | 0.55 |
| ▸ | AVPR1A | P37288 | 10/20 | 0.55 |
| ▸ | OXTR | P30559 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6622674 | 0.87 | AVPR2 (0.72) | AVPR2AVPR1AOXTR | |
| SCHEMBL6625764 | 0.85 | AVPR2 (0.59) | AVPR2AVPR1AOXTR | |
| SCHEMBL6624737 | 0.84 | AVPR2 (0.76) | AVPR2AVPR1AOXTR | |
| SCHEMBL6623967 | 0.84 | AVPR2 (0.58) | AVPR2AVPR1AOXTR | |
| SCHEMBL6624401 | 0.83 | AVPR1A (0.64) | AVPR2AVPR1AOXTR | |
| SCHEMBL6625759 | 0.82 | AVPR2 (0.55) | AVPR2AVPR1AOXTR | |
| SCHEMBL6625133 | 0.81 | AVPR2 (0.56) | AVPR2AVPR1AOXTR | |
| SCHEMBL6623167 | 0.80 | AVPR2 (0.62) | AVPR2AVPR1AOXTR | |
| SCHEMBL6623630 | 0.77 | AVPR2 (0.58) | AVPR2AVPR1AOXTR | |
| SCHEMBL7632997 | 0.74 | AVPR2 (0.41) | AVPR2AVPR1AOXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1000062-B1 | TRICYCLIC VASOPRESSIN AGONISTS | WYETH CORP (US) | 2004-09-22 | — | — | EP | claimed |
| EP-1216045-A2 | VASOPRESSIN AGONIST FORMULATION AND PROCESS | American Cynamid Company (US) | 2002-06-26 | — | — | EP | claimed |
| WO-2001022969-A2 | VASOPRESSIN AGONIST FORMULATION AND PROCESS | AMERICAN CYNAMID COMPANY (US) | 2001-04-05 | — | — | WO | claimed |
| US-6831079-B1 | Oral delivery; nitrogen triheterocyclic active material, surfactant, polyethylene glycol with sucrose fatty acid esters and/or polyvinylpyrrolidone | AMERICAN CYANAMID COMPANY | 2004-12-14 | — | — | US | disclosed |
| EP-1000062-B1 | TRICYCLIC VASOPRESSIN AGONISTS | WYETH CORP (US) | 2004-09-22 | — | — | EP | disclosed |
| US-6511974-B1 | Non-peptidic and have good oral bioavailability, specific vasopressin V2 agonists, therefore do not raise blood pressure | WYETH | 2003-01-28 | — | — | US | disclosed |